PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.
1.75
1.5–2 – Reasonable coverage. Seth Klarman would verify if cyclical factors might push it below comfort levels.
1.75
1.5–2.0 – Good coverage. Seth Klarman might check if seasonal factors affect the ratio significantly.
1.70
1.5–2.0 – Very strong. Benjamin Graham would consider short-term solvency nearly guaranteed.
No Data
No Data available this quarter, please select a different quarter.
-31.30
Negative short-term coverage ratio usually means negative OCF or an outsized near-term debt – a major Graham red flag.